4//SEC Filing
Lee Frank D. 4
Accession 0000899243-22-012463
CIK 0001641281other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 3:21 PM ET
Size
8.4 KB
Accession
0000899243-22-012463
Insider Transaction Report
Form 4
Lee Frank D.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-03-24+22,140→ 22,140 totalExercise: $3.03Exp: 2032-03-23→ Common Stock (22,140 underlying) - Award
Stock Option (Right to Buy)
2022-03-24+14,071→ 14,071 totalExercise: $3.03Exp: 2032-03-23→ Common Stock (14,071 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest in equal monthly installments, at a rate of 1/36th of the total number of shares on each monthly anniversary of November 17, 2021 (the "Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the three-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer.
- [F2]The shares subject to this option shall vest on the one-year anniversary of June 10, 2021 (the "Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the one-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer.
Documents
Issuer
Bolt Biotherapeutics, Inc.
CIK 0001641281
Entity typeother
Related Parties
1- filerCIK 0001814686
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 3:21 PM ET
- Size
- 8.4 KB